Clinical Trial Update: Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults [Phase 3]

View source ↗

Summary

Phase 3 trial update on a three-dose BioThrax regimen for post-exposure prophylaxis in healthy adults, focusing on immunogenicity and safety with completed stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• BioThrax (Anthrax vaccine adsorbed)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Anthrax | Phase 3 | Status: COMPLETED | Results posted: 2013-11-28